肝硬化和壮症患者的凝血功能障碍及其对策:对1522名患者的回顾性研究
Yunfu Lv1, Ning Liu1, Yejuan Li2
1Department of General Surgery, Hainan General Hospital (Hainan Medical College Affiliated People's Hospital), Haikou, 570311 Hainan Province, China.
Disease markers
|June 16, 2023
概括
大约80%的肝硬化和壮症患者经历了凝血功能障碍. 一级和二级患者可以接受手术,而三级患者在考虑手术之前需要初步非手术治疗.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 血液学 血液学 血液学
- 手术瘤学手术瘤学
背景情况:
- 凝血功能障碍常见于肝硬化和壮症患者,影响治疗和预后.
- 了解这种功能障碍的患病率和分级对于患者管理至关重要.
研究的目的:
- 调查肝硬化和壮症患者凝血功能障碍的状态,分级和治疗策略.
主要方法:
- 对1522名肝硬化和壮症患者进行了回顾性队列研究.
- 从2000年1月到2020年12月收集的数据.
- 分析了五项凝血试验:前热血素时间,前热血素活性,激活的部分血栓塑时间,血热血素时间和纤维素原体.
主要成果:
- 80.5%的患者在至少一个测试中表现出凝血功能障碍.
- 凝血功能障碍被分级为I,II和III,基于前热血素时间,激活的部分血栓形成时间和纤维素原.
- 通过等级观察到手术结果的显著差异,而III等级的手术死亡率为6.5%.
结论:
- 凝血功能障碍影响了大多数肝硬化和壮症患者.
- 手术适用于I级和II级患者.
- 三级患者从最初的非手术治疗中受益,只有在凝血功能改善后才考虑手术.
相关概念视频
Disorders of Hemostasis
1.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
767
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
767
Esophageal Varices-II: Clinical Features and Management
100
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
100
Venous Thrombosis IV: Nursing Management
15
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
15
Venous Thrombosis III: Interprofessional Care
11
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
11
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K


